Search research articles
Contact Us
Filters
Showing results (201-210 of 207) with videos related to
Page
of 21
Sort By:
You have reached the last page of results.
This site can display upto 207 results.
The New England Journal of Medicine
|
February 24, 2000
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer
S Braun, K Pantel, P Müller, et al.
Journal of Virology
|
November 1, 1996
Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro
H M Diepolder, M C Jung, E Wierenga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1998
Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial
G Riethmüller, E Holz, G Schlimok, et al.
Scandinavian Journal of Immunology
|
March 1, 1994
Treatment of rheumatoid arthritis with a chimeric CD4 monoclonal antibody (cM-T412): immunopharmacological aspects and mechanisms of action
P A van der Lubbe, C Reiter, A M Miltenburg, et al.
Journal of Virology
|
August 1, 1990
Infection of the human monocytic cell line Mono Mac6 with human immunodeficiency virus types 1 and 2 results in long-term production of virus variants with increased cytopathogenicity for CD4+ T cells
J L'age-Stehr, M Niedrig, H R Gelderblom, et al.
Molecular and Cellular Biology
|
March 22, 2001
Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions
M Balzar, I H Briaire-de Bruijn, H A Rees-Bakker, et al.
Leukemia
|
August 5, 2015
Blockade of the PD-1/PD-L1 axis augments lysis of AML cells by the CD33/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism
C Krupka, P Kufer, R Kischel, et al.
Page
of 21
Search research articles
Search
Showing results (201-210 of 207) with videos related to
Sort By:
Page
of 21
You have reached the last page of results.
This site can display upto 207 results.
The New England Journal of Medicine
|
February 24, 2000
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer
S Braun, K Pantel, P Müller, et al.
Journal of Virology
|
November 1, 1996
Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro
H M Diepolder, M C Jung, E Wierenga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1998
Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial
G Riethmüller, E Holz, G Schlimok, et al.
Scandinavian Journal of Immunology
|
March 1, 1994
Treatment of rheumatoid arthritis with a chimeric CD4 monoclonal antibody (cM-T412): immunopharmacological aspects and mechanisms of action
P A van der Lubbe, C Reiter, A M Miltenburg, et al.
Journal of Virology
|
August 1, 1990
Infection of the human monocytic cell line Mono Mac6 with human immunodeficiency virus types 1 and 2 results in long-term production of virus variants with increased cytopathogenicity for CD4+ T cells
J L'age-Stehr, M Niedrig, H R Gelderblom, et al.
Molecular and Cellular Biology
|
March 22, 2001
Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions
M Balzar, I H Briaire-de Bruijn, H A Rees-Bakker, et al.
Leukemia
|
August 5, 2015
Blockade of the PD-1/PD-L1 axis augments lysis of AML cells by the CD33/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism
C Krupka, P Kufer, R Kischel, et al.
Page
of 21